HCA
IDXX icon

Harbor Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Harbor Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-917
Closed -$447K – 1350
2024
Q2 		$447K Buy
917
+92
+11% +$46.2K 0.03% 548
2024
Q1 		$445K Buy
825
+28
+4% +$15.3K 0.06% 428
2023
Q4 		$442K Sell
797
-131
-14% -$61.5K 0.09% 257
2023
Q3 		$406K Sell
928
-97
-9% -$48.4K 0.09% 256
2023
Q2 		$515K Sell
1,025
-24
-2% -$11.5K 0.1% 241
2023
Q1 		$525K Sell
1,049
-803
-43% -$384K 0.15% 137
2022
Q4 		$756K Sell
1,852
-40
-2% -$15.5K 0.73% 49
2022
Q3 		$616K Sell
1,892
-210
-10% -$77.1K 0.57% 56
2022
Q2 		$737K Sell
2,102
-55
-3% -$22.4K 0.56% 59
2022
Q1 		$1.18M Buy
2,157
+399
+23% +$210K 0.56% 57
2021
Q4 		$1.16M Buy
+1,758
New +$1.1M 0.42% 66

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbor Capital Advisors's IDXX Position: Q3 2024 in Review

Harbor Capital Advisors sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 917 shares — an estimated $447K sold.

Harbor Capital Advisors first reported a position in IDXX in Q4 2021 and held it in 11 quarters. The position peaked at $1.18M in Q1 2022. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Harbor Capital Advisors reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 917 Idexx Laboratories shares in Q3 2024, an estimated $447K.
  • Harbor Capital Advisors first reported a position in Idexx Laboratories in Q4 2021 and held it in 11 quarters.
  • Harbor Capital Advisors's Idexx Laboratories position peaked at $1.18M in Q1 2022.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Harbor Capital Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.